Apr 7, 20231 min readBiotech Stock Catalyst Watchlist - April 2023The first week of April didn't have too many major events, although $IFRX did move +183% on Emergency Use Authorization. Looking forward,...
Apr 7, 20231 min readBiopharma Pulse - 4/3 - 4/7 Weekly Review Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
Apr 6, 20234 min readWhich April '23 PDUFAs are Seeing Run-Ups into Approval Decisions?What Are We Looking At: There are six PDUFA dates in April 2023 for small to large cap biotech. However, a majority of these upcoming...
Apr 3, 20232 min readHow Did Q1 Hedge Fund Top 20 Returns Compare to Other Quarters?Summary: We previously analyzed the 36 life science hedge funds to determine which smid-cap biopharmas were in the most Top 20s See our...
Apr 2, 20231 min readBiotech Stock Catalyst Watchlist - April 2023We've reached the end of Q1. April has a lot of events happening including 8 PDUFA's, the AACR cancer meeting, and some other company...
Mar 31, 20231 min readBiopharma Pulse - 3/27 - 3/31 Weekly Review Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...
Mar 29, 20232 min readAACR Starts April 14th!Last updated 4/10/23 Summary: AACR is only a few weeks away - the conferences starts April 14th, also when abstract text is released What...
Mar 28, 20232 min readAMGN v. Sanofi Ab Patent Case - What Biotech Investors Should KnowAmgen v. Sanofi Sup Ct. oral arguments took place yesterday in the ongoing PCSK9* antibody (Ab) patent case. See the attached transcript...
Mar 24, 20231 min readBiotech Q1 '23 Final Catalyst CountdownWe've reached the final week of Q1. Anything that hasn't read out yet is coming this week! There's over 20 events still set to happen....
Mar 24, 20231 min readBiopharma Pulse - 3/20 - 3/24 Weekly Review Let's review moves from smid-cap biopharma companies during this past week. See Table 1 for weekly moves and moves YTD for companies and...